Chronic Treatment with Nigella sativa Oil Exerts Antimanic Properties and Reduces Brain Inflammation in Rats

Int J Mol Sci. 2024 Feb 2;25(3):1823. doi: 10.3390/ijms25031823.

Abstract

Nigella sativa (NS) is a native herb consumed habitually in several countries worldwide, possessing manifold therapeutic properties. Among them, anti-inflammatory features have been reported, presumably relating to mechanisms involved in the nuclear factor kappa-B pathway, among others. Given the observed association between neuroimmune factors and mental illness, the primary aim of the present study was to examine the effects of chronic NS use on manic-like behavior in rats, as well as analyze levels of brain inflammatory mediators following NS intake. Using male and female rats, baseline tests were performed; thereafter, rats were fed either regular food (control) or NS-containing food (treatment) for four weeks. Following intervention, behavioral tests were induced (an open field test, sucrose consumption test, three-chamber sociality test, and amphetamine-induced hyperactivity test). Subsequently, brain samples were extracted, and inflammatory mediators were evaluated, including interleukin-6, leukotriene B4, prostaglandin E2, tumor necrosis factor-α, and nuclear phosphorylated-p65. Our findings show NS to result in a marked antimanic-like effect, in tandem with a positive modulation of select inflammatory mediators among male and female rats. The findings reinforce the proposed therapeutic advantages relating to NS ingestion.

Keywords: Nigella sativa; behavior; inflammation; mania; mental illness.

MeSH terms

  • Animals
  • Antimanic Agents*
  • Encephalitis* / drug therapy
  • Female
  • Inflammation Mediators
  • Male
  • Nigella sativa*
  • Plant Oils
  • Rats

Substances

  • Nigella sativa oil
  • Antimanic Agents
  • Plant Oils
  • Inflammation Mediators

Grants and funding

This research received no external funding from any source.